Cargando…
Antidepressant Potential of 5-HT(3) Receptor Antagonist, N-n- propyl-3-ethoxyquinoxaline-2-carboxamide (6n)
The present study was designed to evaluate the antidepressant potential of 5-HT3 receptor antagonist N-n-propyl-3-ethoxyquinoxaline-2-carboxamide (6n). The compound ‘6n’ with optimum log P and pA(2) value identified from a series of compounds synthesized in our laboratory was subjected to forced Swi...
Autores principales: | Mahesh, R, Bhatt, S, Devadoss, T, Jindal, AK, Gautam, BK, Pandey, DK |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573375/ https://www.ncbi.nlm.nih.gov/pubmed/23493308 http://dx.doi.org/10.4103/0975-1483.104367 |
Ejemplares similares
-
Antidepressant-like effect of novel 5-HT3 receptor antagonist N-n-butyl-3-ethoxyquinoxalin-2-carboxamide (6p): An approach using rodent behavioral antidepressant tests
por: Bhatt, Shvetank, et al.
Publicado: (2013) -
Antidepressant-like effect of a novel 5-HT(3) receptor antagonist N-(benzo[d] thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide 6k using rodents behavioral battery tests
por: Kurhe, Yeshwant, et al.
Publicado: (2014) -
Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice
por: Kurhe, Yeshwant Vijay, et al.
Publicado: (2014) -
Antidepressant & anxiolytic activities of N-(pyridin-3-yl) quinoxalin-2-carboxamide: A novel serotonin type 3 receptor antagonist in behavioural animal models
por: Pandey, Dilip Kumar, et al.
Publicado: (2016) -
Pharmacological evaluation of novel 5-HT(3) receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery
por: Gupta, Deepali, et al.
Publicado: (2015)